Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs
Federica Giordani(Wellcome Centre for Molecular Parasitology), Michael P. Barrett(University of Glasgow), David Horn(University of Dundee), Michael J. Witty(Global Alliance for Livestock Veterinary Medicines), Jonathan Wilkes(University of Glasgow), Clément Regnault(University of Glasgow), Andrew W. Pountain(The University of Texas Health Science Center), Yvonne R. Freund, Liam J. Morrison(Roslin Institute), Kevin D. Read(University of Dundee), Darren Edwards(University of Dundee), Eva Rico(University of Dundee), Mark C. Field(University of Dundee), Isabel M. Vincent(Wellcome Centre for Molecular Parasitology), Justin J. J. van der Hooft(University of California San Diego), Ning Zhang(Tianjin Children's Hospital), Fernando Fernández-Cortés(Wellcome Centre for Molecular Parasitology), Rosemary Peter(Global Alliance for Livestock Veterinary Medicines), Daniel Paape(Wellcome Centre for Molecular Parasitology)
Cited by 33
Related Papers
The Genome of the African Trypanosome <i>Trypanosoma brucei</i>
|Science|2005|1.7k
Feature-based molecular networking in the GNPS analysis environment
|Nature Methods|2020|1.5k
The Genome Sequence of <i>Trypanosoma cruzi</i> , Etiologic Agent of Chagas Disease
|Science|2005|1.4k
The Genome of the Kinetoplastid Parasite, <i>Leishmania major</i>
|Science|2005|1.4k
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
|PLoS neglected tropical diseases|2017|990